For the Media

Dr. Fred Appelbaum

Dr. Fred Appelbaum is executive vice president and deputy director of Fred Hutchinson Cancer Research Center.  He is a world expert in the research and treatment of blood cancers.  For two decades he served a senior vice president and direction of the Clinical Research Division at Fred Hutch.  

Resources for more information

  • Overview of Fred Appelbaum’s Leadership Focus
    Appelbaum leads Fred Hutch’s strategic research partnerships with the National Institutes of Health and other federal agencies. He also represents the institution to the world at large, developing community relationships and programs needed to sustain the Hutch’s continued growth and impact.
  • Fred Appelbaum – Brief Curriculum Vitae
    Appointments, affiliations and researcher interests.
  • Overview of Fred Appelbaum’s Research
    Appelbaum's research focuses ont he biology and treatment of leukemia, lymphomas and other blood cancers.  He is lead author of the first paper to describe the successful use of autologous bone marrow transplantation, a therapy now used in mor than 30,000 patients annually.
  • Clinical Research Division
    Researchers conduct laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our investigators are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.

FOR THE MEDIA

Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.


 

Photos / Video

Download

Download photos and view video of Fred Appelbaum.

Related Stories


At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.